GlassScriptPhysician profile
Ashan Manohar
NPI 1295725836
$2,690.08
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,980 · 2020: $604 · 2021: $19.86 · 2023: $85.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $85.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $85.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $796.15 | 2019-2023 | |
| Gilead Sciences, INC. | $264.80 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $249.89 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.09 | 2019-2020 | |
| Pfizer INC. | $198.54 | 2019-2020 | |
| Conmed Corporation | $172.71 | 2020 | |
| Dova Pharmaceuticals | $147.04 | 2019 | |
| Janssen Biotech, INC. | $138.11 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.36 | 2019-2020 | |
| Daiichi Sankyo INC. | $72.84 | 2019-2020 | |
| Shire North American Group INC | $57.84 | 2019 | |
| Merck Sharp & Dohme LLC | $52.44 | 2019 | |
| Ferring Pharmaceuticals INC. | $39.10 | 2019 | |
| Qol Medical, LLC | $38.46 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $32.13 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $29.22 | 2019 | |
| Ucb, INC. | $22.94 | 2020 | |
| Romark Laboratories, Lc | $13.41 | 2019 | |
| Allergan, INC. | $11.11 | 2019 | |
| Ironwood Pharmaceuticals, INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashan Manohar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.